chrisvoncsefalvay/vaers-outcomes huggingface dataset:
WEAKNESS; TIREDNESS; PAIN AT SITE OF INJECTION; This spontaneous report received from a patient concerned a 74 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known drug allergies. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: 1816027, expiry: 01-JUL-2021) dose was not reported, administered on 19-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On MAY-2021, the subject  experienced pain at site of injection. On 20-MAY-2021, the subject experienced weakness. On 20-MAY-2021, the subject experienced tiredness. The action taken with covid-19 vaccine was not applicable. The patient recovered from pain at site of injection on MAY-2021, had not recovered from weakness, and the outcome of tiredness was not reported. This report was non-serious.
Injection administered via Subcutaneous on back on left arm. Red spot about the size of a baseball developed around site, the night the injection was administered. By the next day, redness, swelling, and itching down to the elbow occurred. The spot the size of the baseball has now turned purple. This lasted approximately a week. The injection was administered on 11-16-17 and today 12-04-17, the bruise is still present on the back of my arm.
patient was give two 2nd doses at same clinic moments apart. there were two consent forms (one printed & one paper copy), one was handed to one nurse she vaccinated, and then another was handed to 2nd nurse where she vaccinated.. facility takes responsibility for issue as they directed him into the room twice and also had 2 consent forms for him present. there are currently no adverse reactions
While sitting in a chair after vaccination, patient reported that she started feeling tightness in her chest. Nurse checked her vital signs: BP 152/113, Pulse 63, Pulse Ox 98%, Temp 98.3F. Patient was placed on a gurney and monitored vital signs every 15 minutes. VS at 10:45: BP 172/111, Pulse 67, Respiration 20, Pulse Ox 97%. patient reported feeling dizzy and her throat was slightly tightening, but did not have difficulty breathing. VS at 11:00AM: BP 145/, Pulse 63; at 11:15AM BP 133/80, Pulse 63. Patient remained in the gurney until 12PM. Her vital signs remained in normal range. Patient said her tightness in chest and throat were coming and going but not getting worse. She sat in a chair at 12PM until 12:30PM. Patient left the vaccination center around 12:30PM on her own.  She said she had an Epi Pen in her car and knew how to use it. She said she had to leave to pick up her daughter from school. Nurse recommended patient to continue monitor her symptoms and consult her doctor as needed.
This case was reported by a healthcare professional and described the occurrence of injection site inflammation in a child subject of unspecified gender who was vaccinated with KINRIX (GlaxoSmithKline). Concurrent vaccination included MMR vaccine (non-gsk); non-GSK manufacturer; unknown given on an unspecified date; varicella virus vaccine; manufacturer unspecified; unknown given on an unspecified date. On either 28 March 2011, 29 March 2011, 2 April 2011, 8 April 2011 or 13 April 2011 the subject received unspecified dose of KINRIX (unknown route, unknown arm). Less than one month after vaccination with KINRIX, the subject experienced injection site inflammation, swelling injection site and injection site soreness. At the time of reporting the outcome of the events was unspecified. The healthcare professional reported that 7 children experienced the same side effects after receiving KINRIX vaccine. The vaccine was administered on 28 March, 29 March, 2 April, 8 April, and 13 April 2011. This is case 4 of 7; see case IDs A0924034A, A0924036A, A0924037A, A0924039A-A0924041A for details of the other reports.
She's developed an itchy rash, like dermatitis, "on my upper arms and from my kneecaps down to my ankle; She's developed an itchy rash, like dermatitis, "on my upper arms and from my kneecaps down to my ankle; This is a spontaneous report from a contactable consumer (patient). A female patient of unspecified age received her second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date not reported), via an unspecified route of administration on an unspecified date (at an unspecified age) at 2nd dose, single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously took paracetamol (TYLENOL) for small rash that didn't itch, feeling tired, and headache. Historical vaccine included first dose of BNT162B2 received on an unspecified date for COVID-19 immunization, where the patient experienced small rash that didn't itch, feeling tired, and headache. The patient treated her symptoms by taking 2 paracetamol (TYLENOL), and symptoms resolved. The patient reported of receiving both doses of Pfizer COVID-19 vaccine. But after the second dose, the patient developed an itchy rash, like dermatitis, on the patient's upper arms and from her kneecaps down to her ankle. The patient received a steroid cream as a treatment for the events. Outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
CDC reports: 7 mo infant developed fever to 105 & muscle spasms following DTP/OPV immunization, lasted 2 days.
Metallic taste in Mouth; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (Metallic taste in Mouth) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced DYSGEUSIA (Metallic taste in Mouth). On 22-Mar-2021, DYSGEUSIA (Metallic taste in Mouth) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.  Treatment medication was not provided by the reporter.
red bumps on legs, front torso and up to hip; scratching R arm from writs to elbow/itching inside L arm from wrist to elbow; pinkish reaction on R arm from wrist to elbow; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRURITUS (scratching R arm from writs to elbow/itching inside L arm from wrist to elbow), VACCINATION SITE DISCOLOURATION (pinkish reaction on R arm from wrist to elbow) and ERYTHEMA (red bumps on legs, front torso and up to hip) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042120A) for COVID-19 vaccination.     Concurrent medical conditions included Allergic reaction (Temperature extremes makes her react with bumps on back.). Concomitant products included VITAMINS NOS for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced PRURITUS (scratching R arm from writs to elbow/itching inside L arm from wrist to elbow) and VACCINATION SITE DISCOLOURATION (pinkish reaction on R arm from wrist to elbow). On an unknown date, the patient experienced ERYTHEMA (red bumps on legs, front torso and up to hip). In January 2021, PRURITUS (scratching R arm from writs to elbow/itching inside L arm from wrist to elbow) and VACCINATION SITE DISCOLOURATION (pinkish reaction on R arm from wrist to elbow) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   concomitants- bariatric medicine,osteoporosis medicine, for bladder sensitivity Treatment information as not reported.   This case was linked to MOD-2021-044321 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 01-Apr-2021: Patient not interested in follow up - NNI; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Information has been received concerning a 2 month old female who on 1/4/02 was vaccinated  with the first dose of Haemophilus B conjugate vaccine, hepatitis B vaccine recombinant (yeast) IM in the right leg (lot #09516-invalid). Concomitant therapy that same day included the first dose of diphtheria toxoid/pertussis vaccine/tetanus toxoid (INFANRIX) IM in the left leg (lot #522A2), the first dose of poliovirus vaccine (IPOL) SC in the left leg (lot #T1454), the first dose of Streptococcus pneumoniae vaccine (PREVNAR) IM in the right leg (lot #484146). Other concomitant therapy included acetaminophen (TYLENOL) (PARACETAMOL). Within 20-35 minutes post-vaccination, the patient experienced an apneic episode and was hospitalized for 2 days. This was originally reported by a health professional. Follow up information was received from manufacturer on 9/4/02. No further medically significant information was provided. No further information is available.
Information has been received from a physician assistant (PA) concerning an approximately 6 to 7 month old patient with no medical history or allergies who on unspecified dates was vaccinated po with all three doses of ROTATEQ. There was no concomitant medication. The PA reported the patient experienced intussusception and was hospitalized (no time frame was available). The patient's outcome was not reported. Additional information has been requested.  6/16/2008 MR received for 2 ER visits 1/8/08 and 1/19/2008 with DX:  Intussusception. 2nd visit for not eating well s/p IS. infant presented with 12 hr hx of vomiting as well as crying as if in pain. Taking nothing po. IS noted on Barium enema but uncuccessful at reducing.  Transfered to higher level of care.  7/10/2008 MR received for DOS 1/9-11/2008 with D/C Dx Intussusception s/p reduction and appendectomy. Infant received for transfer s/p unsuccessful BE reduction.  Pt taken to OR for laparotomy and reduction with appendectomy and lymph node biopsy. Did well post-op and d/c home
Appoximately 12:15pm patient Reporting itching all over her body, throat feeling scratchy, bumps forming on chest, ear itching. Vital signs taken Benedryl 12.5 mg given IM x2. pepcid given orally, continued to monitor x 60 min. Itching was Reduced over body, bumps on skin Resolved. Temperature Rose from 97.2F to 99.4F.
Along with flu-like symptoms fatigue, coughing, and extra phlegm production. This started at the beginning of December and got progressively worse up until 12/24. At urgent care they gave a CoVid test and came back negative. After a physical exam, doctor prescribed codeine-guaifenesin and Claritin-D. After 2-3 days felt much better and feel recovered. Only an occasional dry cough remains from time to time.
this patient died at home on 1/30/22; there was a post-mortem COVID test done on 1/31/22 that was positive; there are no medical records on this patient
A stream of blood was dripping down arm at the moment of the needle being removed from my arm.; This is a spontaneous report from a contactable consumer (patient) reported for herself.  A 55-year-old (report "age at vaccination: 55 years" and "current age: 55") female patient (pregnant: no) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via unspecified rout of administration at left arm on 07Jan2021 02:00 PM at single dose for COVID-19 immunization. Medical history included Heart murmur, known allergies to sulfites, latex and ingredients in common suntan lotion. Patient received within 2 weeks of vaccination included ibuprofin, OTC sleeping pills, multivitamin, C. the patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient used took monosodium glutamate (MSG) and doxycycline and had allergy to them. It was reported stream of blood was dripping down arm at the moment of the needle being removed from her arm on 07Jan2021 on 02:00 PM. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. It was non serious case. Not results in death, Life threatening, caused/prolonged hospitalization, Disabling/Incapacitating nor congenital anomaly/birth defect. No treatment received for the event. Outcome of the event was unknown.   Information on the lot/batch number has been requested.
1st dizzy distant feelings, hard to walk or think. later sleepy, legs aches body aches,  severe headache ears teeth ache, chills muscle spasms, sensitivity to lite, smells, nausea, vomiting, diarrhea extreme fatigue dizziness and inability to think correctly. worst part lasted for 36 hrs, Felt human after 5 days
Intense arm pain at site of injection felt approximately 6 hours after injection. Flu-like symptoms including headache, runny nose, sore throat, nausea, heartburn, fatigue, and dry cough experienced approximately 24 hours after injection. Also feeling of racing or fluttering heartbeat These symptoms worsened over the following 24 hours. 70 hours from injection experiencing headache, nausea, heartburn, racing heartbeat, sore throat, runny nose, dry cough, muscle aches, and fatigue.
Patient should have recieved a certain dose but recieved an adult dose of Bivalent.
about 3 hrs p/vax pt devel a high fever 105, & then had a sz; pt was taken to ER & kept overnoc for observation; mom states pt had inc WBC's & OM;
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. No concurrent conditions, medical history or allergy/drug reactions were reported. On 25-APR-2016, the patient was inadvertently administered with GARDASIL (dosing details were not reported) lot # J006850, expiry: 25-APR-2016 intramuscularly. It was confirmed by the primary reporter which dose in the series of three was administered. No adverse effects reported. There were no product quality complaints (PQC) involved. Additional information has been requested.
Swelling of hands, redness of skin, generalized itching day of vaccine. Symptoms progressed over 3 days to swelling of hands and feet, redness of hands and feet, itchy throat, no difficulty swallowing. Feels puffy all over.
8/7/2021 at 8:00 pm I noticed after dinner my heartrate went up to 125, my palms were sweaty, and my hearing decreased. The adverse event lasted less than 3 minutes. I rested as for treatment. The outcome did not resolve due to I had another adverse event on 8/10/2021. 8/10/2021 around 2:00 pm I was changing clothes upstairs and I noticed my heart was racing, my hearing decreased, and my right calf went numb under 3 minutes. I went downstairs to rest but then I had to change my daughter on the floor and I noticed my heart was racing again and my hearing decreased. I noticed my heartrate went up to 147 on my pulse oximeter and my Apple watch noticed it. I went to the ER and they did an ECG. This outcome did not resolve due to my second vaccination my heartrate went up to 161 after I received my dose in less than 10 min.
This is in follow-up to report(s) previously submitted on 2/18/2008. Initial and follow-up information has been received from a consumer concerning her 12 month old son with no pertinent medical history who on approximately 14-JUL-2005 was vaccinated with a dose of hib conj vaccine (OMPC). In November 2007 the patient was vaccinated with a dose of Hib conj vaccine (OMPC) (Lot# 656522/0437U). There was no concomitant medication. On 27-NOV-2007, the patient experienced a lump, the size of a penny, at the injection site and injection site swelling. There was no laboratory or diagnostic tests performed. Unspecified medical attention was sought. Subsequently, the patient recovered. Follow-up information indicated that the adverse events were not related to the vaccination. Additional information is not expected.
Started at 1:15AM with chills and shivering for 45 min. 5:30 AM woke up with 106 degree temp, put the dogs out to try and cool down went back to bed woke up at 6:30 temp was 104.8 degrees. I took a cool shower to bring temp down and gave the wife time to take care of the animals before going to the ER. Temp was down to 102.3 at 7:20. Took Tylenol and laid back down with a fan on me, temp came down to 100 by 8:00. Stayed in bed and temp came down to 98. Laid back down at 1:45 temp was 98, woke up at 3:10 and temp was 103, went outside to bring it down at 4:00 temp was down to 100 and slowly. Went to bed at 8:30 temp was 98 and stayed down all night. Injection site stayed sore till 4/6/21.
Chills a couple hours overnight. Woke up on 12/17/20 with a moderate headache.
SOMETHING BAD IN HEART, LIKE FEELING A BOOM BOOM; CHILLS; FEEL COOL; DONT FEEL GOOD; A LITTLE FEVER; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 01-OCT-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On 01-OCT-2021, the patient experienced something bad in heart, like feeling a boom boom. On 01-OCT-2021, the patient experienced chills. On 01-OCT-2021, the patient experienced feel cool. On 01-OCT-2021, the patient experienced dont feel good. On 01-OCT-2021, the patient experienced a little fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from chills, feel cool, a little fever, something bad in heart, like feeling a boom boom, and dont feel good. This report was non-serious.
Patient received a 3rd shot of pfizer covid 19 due to autoimmune disease. She has experienced nausea, vomiting, aches and pains and diarrhea since her vaccine on 8/30/21. Time of reporting to pharmacy is now 9/22/21. I strongly advised the patient to be evaluated by a medical doctor and told her the side effects should have resolved within 72 hours.
Information has been received on 15-NOV-2018 from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. The patient's healthcare provider, recommended and/or prescribed ZOSTAVAX (lot# and route unknown) to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On 01-NOV-2017, a healthcare provider at a pharmacy administered the ZOSTAVAX vaccine to the patient. On 07-NOV-2017, the patient was treated by a healthcare provider for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. The patient used the ZOSTAVAX vaccine for the permanent prevention of shingles and zoster-related injuries. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. Additional information has been requested.
No additional AE reported.; at least one dose of PNEUMOVAX 23 was administered following a temperature excursion.; This spontaneous report has been received from a nurse referring a patient of a unknown age and gender.  The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.  On 27-JUN-2022, the patient was vaccinated with an improperly stored pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) 1 syringes, lot number U034712, expiration date: 30-JUL-2023, as prophylaxis (strength, vaccination scheme, anatomical location and route of administration were not provided) following a temperature excursion of 58.3 degrees Fahrenheit (F) for 8 hours (product storage error), there was stated that no previous temperature excursion occurred. No additional adverse event was reported.
Information has been received from the physician concerning a current 80 year old retired caterer, female patient with no pre-existing allergies or other medical conditions, "none" illness at time of vaccination and with a history of chickenpox in the childhood and with no recent exposure to chickenpox or Herpes Zoster (also reported as having developed shingles resulting in a post-herpetic neuralgia after prior vaccination with the first dose of ZOSTAVAX (Merck), on an unspecified date at the age of 79 year old). On 19-JUN-2010, at an unknown time, the patient was vaccinated with the second "usual adult dose" of ZOSTAVAX (Merck) at the local pharmacy. There were no concomitant medications. After the second dose of ZOSTAVAX (Merck), on 20-JUN-2010, the patient experienced pain. On 22-JUN-2010, the patient developed a rash. On 23-JUN-2010, the patient developed classic shingles (also reported as grouped clusters and vesicles) that appeared along dermatomes right thoracic 5-6 from back to lower breast/chest. Other symptoms included pleuritic chest pain in a grade of 10 (scale 0 to 10). Then patient developed a "severe and persistent" post-herpetic neuralgia which interfered her sleep for months and persisted for months. The patient had multiple attempts at pain control (unspecified). Diagnostic tests included a clinical exam (results not provided). No direct fluorescent antibody test and PCR test were done. At the time of the report the patient had not recovered. The patient required emergency room/doctor visits. The patient's shingles pain was considered disabling by the reporting physician. This is one of several reports received from the same source. Additional information has been requested.
Pt complaining of muscle soreness in her left shoulder/upper arm area that started immediately after getting flu shot. Patient describes pain a couple inches below her left shoulder in her arm. When asked to describe the pain, she states is like a "tooth ache", an ache, not a sharp stabbing pain. No redness or swelling is present at the area. Today while at shopping market, she noticed significant discomfort and pain on top of her shoulder, such that to the point she no longer utilized her arm to push her cart. She mentions during my conversation with her that she thought it was odd at how high the pharmacist who gave her the flu shot had gone on her arm and even mentioned it to her friend after getting the shot. Patient called over weekend to make us aware, and to see if anyone else had presented with the same issues. To my knowledge, no one has presented to the pharmacy with any similar complaint. Pt states she is uncomfortable enough such that she has made a doctors appt 11/24/20 for an evaluation.
Passed out within 3 minutes of receiving injection. Hit her head on the wall as she passed out and fell to the floor . Ambulance called - refused transport to hospital.  Mother stated she would take her to the ER.